Cases & Deals

Share

Ventac invests in multimmune

September 2008

Client(s) Ventac Partners GmbH

Jones Day counseled Ventac Partners GmbH in connection with its purchase of Common Stock in a private placement by multimmune GmbH, a private biopharmaceutical company focused on the development of innovative therapeutic approaches for the treatment of cancers.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.